Corporate ActionAug 7, 2026, 05:28 PM
DataMeds AI Registers 34.46M Shares for Resale; Changes Name
AI Summary
DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) filed an S-1 registration statement for the resale of up to 34,462,058 shares of common stock by selling stockholders, stemming from recent financings. The company recently changed its name and ticker symbol, completed a 1-for-50 reverse stock split, and is addressing Nasdaq listing compliance issues. Additionally, DataMeds AI announced a proposed transaction via an amended letter of intent and a new Interim Co-CEO.
Key Highlights
- DataMeds AI (formerly Wellgistics Health) registered 34,462,058 common shares for resale by selling stockholders.
- Company changed its name to DataMeds AI, Inc. and ticker to MEDS on July 22, 2026.
- Completed May 2026 financing, issuing $21.13 million in convertible notes and warrants.
- Effected a 1-for-50 reverse stock split on May 26, 2026.
- Regained Nasdaq minimum bid price compliance but remains non-compliant with $2.5 million stockholders' equity.
- Entered into an amended LOI for a proposed transaction with EOS, Scilex, Datavault, and HealthBridge Advisors.
- Gerald Commissiong appointed Interim Co-Chief Executive Officer on May 20, 2026.
Price Impact
More from WGRX